Key market opportunities in cell and gene therapy include tracking investment trends, analyzing key deals, and staying updated with scientific developments and market forecasts. The publication is ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Hospitals excel at designing services fit for their needs. A pediatric cancer center of excellence, for example, is likely to produce superior outcomes due to its robust, experienced, cross-functional ...

The first half of 2025 has been a notable one for Cellares. The cell therapy manufacturer operates its first commercial-scale Integrated Development and Manufacturing Organization Smart Factory in ...

The "Cell & Gene Therapy Cold Chain Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, ...

The National Institute for Health and Care Excellence (NICE) has approved a chimeric antigen receptor (CAR) T-cell therapy for adults with large B-cell lymphoma. The treatment significantly delays ...

Stem cell therapy updates medical practices by creating new ways to treat orthopedic problems and health degenerations. Patients confront the largest problem when considering treatment-associated ...

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

While chimeric antigen receptor (CAR) T cell therapy is an essential therapeutic option for prolonging survival in patients with relapsed or refractory non-Hodgkin lymphomas (NHL), profound immune ...

Auggie, a Great Pyrenees, was successfully treated with VetStem Cell Therapy for osteoarthritis in his hips. Auggie ...